chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Muscular weakness, Musculoskeletal pain, Neck pain, Pain in extremity
Clinical narrative: Case previously recorded as MA2009-3759. Initial case report received from a registered nurse on 10 NOV 2009. A 54-year-old female patient was vaccinated with 0.5 mL of S-OIV FLUVIRIN (batch no. 101716P1A) i.m. in left deltoid on 26 OCT 2009. She had a complaint of progressive soreness of the upper left arm; pain progressed to neck and shoulder with weakness of arm. No numbness, no tingling of left upper extremity was observed. The patient does not have pain at site of vaccination. Follow up information received on 12 NOV 2009: No significant information received. Follow up report received on 26 Apr 2010: There was an attempt to contact reporter, but no response received so far. Therefore the case was closed with a consideration as a lost to follow up.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Diarrhoea, Dyspepsia, Hot flush, Nausea, Pyrexia
Clinical narrative: Case previously recorded as MA2009-3763. Initial case report received from a consumer via MedCom on 06 NOV 2009. A 54 year-old female patient was vaccinated with 0.5 mL of S-OIV FLUVIRIN (batch no. unknown) i.m on 04 OCT 2009. The patient experienced hot flashes, nausea, heartburn, diarrhea and low grade fever one hour after receiving the vaccination. The patient did not recover at time of this report. MedCom reference no.: NA09-007700.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-3819. Initial case report received from a nurse on 11 NOV 2009. A patient 35-year-old female was vaccinated into the deltoid with 0.5 mL S-OIV FLUVIRIN (batch no. unknown) i.m on 28 OCT 2009. The patient was unaware that she was pregnant (8th week of gestation) at the time of the vaccination. No adverse event was reported.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Muscular weakness
Clinical narrative: Case previously recorded as MA2009-3829. Initial case report received from a consumer via Novartis Medical Communications on 06 NOV 2009. A 52 year-old female patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. unknown) i.m., on 02 NOV 2009. On 03 NOV 2009, the patient experienced a left leg weakness, feeling it "pulverized". The outcome of the events was reported as not recovered. MedCom reference no.: NA09-007773.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-4029. Initial case report received from a physician via MedCom, on 05 NOV 2009. A 33 year-old female patient was vaccinated during pregnancy with 0.5 mL of S-OIV FLUVIRIN (batch no. 100738) i.m. on 03 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-007596.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy
Clinical narrative: Case previously recorded as MA2009-4030. Initial case report received form a physician via MedCom on 05 NOV 2009. A 28 year-old female patient was vaccinated during pregnancy with 0.5 mL of S-OIV FLUVIRIN (batch no. 100738) i.m. on 03 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-007596.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-4031. Initial case report received from a physician via MedCom on 05 NOV 2009. A 30-year-old female patient was vaccinated during pregnancy with 0.5 mL of S-OIV FLUVIRIN (batch no. 100738) i.m on 03 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-007596.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-0432. Initial case report received from a physician via MedCom on 05 NOV 2009. A 34 year-old female patient was vaccinated during pregnancy with 0.5 mL of S-OIV FLUVIRIN (batch no. 100738) i.m on 03 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-007596.
Age: 33.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-4033. Initial case report received from a physician via agency, on 05 NOV 2009. A 33 year-old female patient was vaccinated during pregnancy with 0.5 mL of S-OIV FLUVIRIN (batch no. 100738) i.m on 03 NOV 2009. No adverse events were reported. Agency reference no.: NA09-007596.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy, No adverse event
Clinical narrative: Case previously recorded as MA2009-4034. Initial case report received from a physician via MedCom on 05 NOV 2009. A 34 year-old female patient was vaccinated during pregnancy with 0.5mL of S-OIV FLUVIRIN (batch no. 100738) i.m. on 03 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-007596.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Drug exposure during pregnancy
Clinical narrative: Case previously recorded as MA2009-4261. Initial case report received from a consumer via Novartis on 13 NOV 2009. A 44-year-old female patient was vaccinated during pregnancy with FLUVIRIN (batch no. unknown), on 10 NOV 2009. MedCom reference no.: NA09-008182. Reference #: S2009US25756.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: Case previously recorded as MA2009-4313. Initial case report received from a health care professional via MedCom on 16 NOV 2009. A 54 year-old female patient was vaccinated with S-OIV FLUVIRIN (batch no. 101716P1A) i.m. on 10 NOV 2009. The patient experienced tingling that began in feet and traveled to arms on 11 NOV 2009. The patient felt worse on 14 and 15 NOV 2009. On 16 NOV 2009, patient exam showed motor function to be normal, normal speech and grip strength, and normal respiration. No treatment was given. The patient did not recover at time of this report. MedCom reference no.: NA09-008292.
Age: 41.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dysphonia, Pruritus, Urticaria, Wheezing
Clinical narrative: Case previously recorded as MA2009-4340. Received the following information via Medical Communications from a healthcare professional on 17 NOV 2009: A 41-year-old female patient was vaccinated i.m with S-OIV FLUVIRIN (batch number 1009221P1) on 10 NOV 2009 at 05:00 p.m. Within one hour after vaccination the patient experienced an itchy sensation, raspy voice and hives. The following morning she began to have wheezing and was treated with some steroids. The adverse event resolved shortly after the steroid treatment. MedCom ref. no.: NA09-008343.
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Musculoskeletal stiffness, Pain
Clinical narrative: Case previously recorded as MA2009-4408. Initial case report received from a consumer on 07 NOV 2009. A female patient was vaccinated with of S-OIV FLUVIRIN (batch no. unknown) on 12 OCT 2009. The patient experienced mild body aches and stiff neck for one day after vaccination and a local ache in injection site for one week after vaccination. The outcome of the events was reported as recovered.
Sex: U
Vaccine: FLU3
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch no: 104045P1) 0.5 ml, intramuscular, that had been stored at temperatures as low as 34 F and 35 F on an unspecified date. No adverse event was reported.
Sex: M
Vaccine: FLU3
Symptoms: Incorrect storage of drug
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.5 ml on an unknown date with a vaccine stored at temperatures as low as 34 F and 35 F. No adverse event was reported.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch no.: 104045P1) on an unknown date. One dose of influenza vaccine that had been stored at temperatures as low as 34F and 35 F was given to an adult. No adverse effect was reported.
Sex: F
Vaccine: FLU3
Symptoms: No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with FLUVIRIN an unknown batch number, 0.5 ml on an unknown date with a vaccine stored at temperatures as low as 34 F and 35 F. No adverse event was reported.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch no. 104045P1) on an unknown date. One dose of influenza vaccine that had been stored at temperatures as low as 34F and 35F was given to an adult. No adverse effect was reported.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch: 104045P1) 0.5 ml once, intramuscular, stored at temperatures as low as 34 F and 35 F on an unspecified date. No adverse event was reported.
Age: 59.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a Pharmacist on 15 Jan 2010: This patient, with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (Batch number 104045P1), intramuscularly, on an unspecified date. The FLUVIRIN vaccine was stored at a temperature which was as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported.
Age: 92.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a Pharmacist on 15 Jan 2010: This patient, with an unknown medical history, was vaccinated with one dose of FLUVIRIN (batch no. 104045P1), 0.5 ml, intramuscularly, on an unspecified date. The FLUVIRIN vaccine had been stored at temperatures as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported. No further information was provided.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch: 104045P1, expiry date 30 Apr 2010) 0.5 ml once, intramuscular, stored at temperatures as low as 34 F and 35 F, on an unspecified date. No adverse event was reported.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with 0.5 ml of FLUVIRIN vaccine (batch number: 104045P1) intramuscularly on an unknown date. It was reported that the vaccine was stored at temperatures as low as 34F and 35F. No adverse effect was reported. No seriousness criteria was provided.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from pharmacist on 15 Jan 2010: This patient received FLUVIRIN, batch number 104045P1 expiration date 30 Apr 2010, 0.5 ml intramuscular, on an unknown date, which was stored at temperatures as low as 34F and 35F. No adverse event was reported.
Age: 79.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient, with an unknown medical history, was vaccinated with one dose of FLUVIRIN (batch no. 104045P1), 0.5 ml, intramuscularly, on an unspecified date. The FLUVIRIN vaccine had been stored at temperatures as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported. No further information was provided.
Age: 80.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a Pharmacist on 15 JAN 2010: This patient, with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (Batch number 104045P1), intramuscularly, on an unspecified date. The FLUVIRIN vaccine was stored at a temperature which was as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported.
Age: 84.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient, with an unknown medical history, was vaccinated with one dose of FLUVIRIN (lot no. 104045P1), 0.5 ml, intramuscularly, on an unspecified date. The FLUVIRIN vaccine had been stored at temperatures as low as 34 degrees Fahrenheit and 35 degrees Fahrenheit. No adverse event was reported. No further information was provided.
Age: 1.92
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from a healthcare professional on 15 Jan 2010: This patient, who was a 1 year old child, received FLUVIRIN lot no. 102140P1, 0.5 ml intramuscular on 14 Jan 2010. No adverse event as reported.
Sex: M
Vaccine: FLU3
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.5 ml on unknown date which was stored at temperatures as low as 34F and 35 F. No adverse event was reported.
Sex: F
Vaccine: FLU3
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.25 ml on unknown date which was stored at temperatures as low as 34F and 35 F. No adverse event was reported. After an internal review on 21 Jan 2010 for the data received on 15 Jan 2010: A non-significant correction was done about the dosage of the vaccine was 0.5 ml and not as 0.25 ml as previously reported.
Age: 1.61
Sex: F
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.25 ml on 14 Jan 2010 for an inadvertent administration.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from pharmacist on 15 Jan 2010: This patient received FLUVIRIN, batch number 104045P1, expiration date 30 Apr 2010, 0.5 ml on an unknown date, which was stored at temperatures as low as 34F and 35F. No adverse event was reported.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6274. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Agency reference no. NA09-008851.
Sex: U
Vaccine: FLU3
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.5 ml on an unknown date with a vaccine stored at temperatures as low as 34 F and 35 F. No adverse event reported.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6275. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reports. Medical history: Not reported. Agency reference no. NA09-008851.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6276. Initial case received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN influenza A intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Agency reference no. NA09-008851.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.5 ml on unknown date which was stored at temperatures as low as 34F and 35 F. No adverse event was reported.
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch: 104045P1) 0.5 ml once, intramuscular, stored at temperatures as low as 34 F and 35 F  on an unspecified date. No adverse event was reported.
Age: 3.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6289. Initial case report received via MedCom from a physician on 25 NOV 2009: A 3year-old female child, was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 102041P1) i.m. on 25 NOV 2009. No adverse event was reported. Rev. no.: NA09-008864.
Age: 1.74
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6291. Initial case report received via MedCom from a physician on 25 NOV 2009: A 21-month-old male child was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 102129P1) i.m. on 25 NOV 2009. No adverse event was reported. Ref. no.: NA09-008870.
Sex: U
Vaccine: FLU3
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6295. Case received on 25 NOV 2009 via MedComfrom healthcare professional the following information: An unspecified number of children younger than 4 years was vaccinated i.m. with FLUVIRIN, batch no. unknown, on unknown dates. No events were reported. No further information available. MedCom no:NA09-008809.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6438. We received the following information via Medical Communications (MedCom) from a physician on 30 NOV 2009: Three patients younger than four received a dose of S-OIV FLUVIRIN (batch number 1007369P) i.m. on an unspecified date. Despite multiple attempts to obtain details such as patient initials the reporter declined to provide additional information. No adverse effects was reported. This case concerns one of the three patients for the other two children please refer to cases MA2009-6439 and MA2009-6440. MedCom ref. no.: NA09-008948.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6439. We received the following information via Medical Communications (MedCom) from a physician on 30 NOV 2009: Three patients younger than four received a dose of S-OIV FLUVIRIN (batch number 1007369P) i.m. on an unspecified date. Despite multiple attempts to obtain details such as patient initials the reporter declined to provide additional information. No adverse effects were reported. This case concerns one of the three patients for the other two children please refer to cases MA2009-6438 and MA2009-6440. MedCom ref. no.: NA09-008948.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch:104045P1) 0.5 ml once, intramuscular, stored at temperatures as low as 34 F and 35 F on an unspecified date. No adverse event was reported.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6440. We received the following information via Medical Communications (MedCom) from a physician on 30 NOV 2009: Three patients younger than four received a dose of S-OIV FLUVIRIN (batch number 1007369P) i.m. on an unspecified date. Despite multiple attempts to obtain details such as patient initials the reporter declined to provide additional information. No adverse effects was reported. This case concerns one of the three patient for the other two children please refer to cases MA2009-6438 and MA2009-6439. No seriousness criterion given. MedCom ref. no.: NA09-008948.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: Initial report received from a pharmacist on 15 Jan 2010: The patient was vaccinated with FLUVIRIN (batch: 104045P1, expiry date 30 Apr 2010) 0.5 ml once, intramuscular, stored at temperatures as low as 34 F and 35 F, on an unspecified date. No adverse event was reported.
Age: 1.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6444. Initial case report received from a healthcare professional on 20 NOV 2009. This 1-year-old child was vaccinated for the first time with S-OIV FLUVIRIN (batch no. unknown) on an unknown date. No adverse event appeared. Reference no. NA09-008973.
Age: 3.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6446. Initial case report received via Med Com from a health care professional on 30 NOV 2009: A 3-year-old patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. unknown) i.m. on 30 NOV 2009. No adverse event was reported. MedCom ref. no.: NA09-008951.
Age: 1.42
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6459. Initial case report received via Med Com from a health care professional on 30 NOV 2009: A 2-year-old male patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 101263P) i.m. on 30 NOV 2009. No adverse event was reported. MedCom ref. no.: NA09-008898.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6460. Initial case report received via Med Com from a health care professional on 30 NOV 2009. A 2-year-old male patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 1013263P) on 30 NOV 2009. No adverse event was reported. MedCom ref. no.: NA09-008898.
Age: 1.02
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-6468. Initial case report received via Med Com from a health care professional on 30 NOV 2009: A 1-year-old female patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 10007396P) on 30 NOV 2009. No adverse event was reported. MedCom ref. no.: NA09-008919.
Age: 1.29
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 04 Jan 2010: This patient, with an unknown medical history was inadvertently administered FLUVIRIN, intramuscularly on 04 Jan 2010. The outcome of the event was not reported. No other information was provided.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Nasopharyngitis, Vomiting
Clinical narrative: Initial consumer report received on 04 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN (batch no. 102134P1) on 18 Dec 2009. The patient vomited and presented with cold like symptoms on 25 Dec 2009. The events resolved on Dec09. Outcome of the events was reported as condition unchanged.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 05 Jan 2010: This two year old patient inadvertently received S-OIV FLUVIRIN, batch no: 1021314P1, intramuscularly, on 04 Jan 2010.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 06 Jan 2010: This patient received one dose of the Novartis H1N1 vaccine (batch no. 102132P1) intramuscular, on 05 Jan 2010. The outcome of the event was not reported. Following an internal review on 29 Jan 2010 of the data received on 06 Jan 2010 the following correction was made: The suspect drug was recoded to S-OIV FLUVIRIN.
Age: 50.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Mobility decreased, Myalgia, Neuralgia, Paraesthesia, X-ray
Clinical narrative: Combined Initial and follow up report received from a health care professional on 06 Jan 2010 and on 07 Jan 2010: This patient was received FLUVIRIN on 17 Dec 2009. At an unspecified time shortly after vaccination, she began to experience neuralgia, myalgia and difficulty in lifting her left arm and experienced tingling in her left arm in the morning. She saw her physician on 06 Jan 2010; the physician ordered an X-ray (no results available at the time of the report). VICODIN, VOLTAREN gel, and a MEDROL pack were prescribed for the patient on 06 Jan 10. She was to follow up with the MD in 2 weeks (around 20 Jan 2010). The events myalgia, neuralgia, tingling in the morning, and difficulty lifting her left arm were ongoing.
Age: 0.59
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 06 Jan 2010: This 8 months old child was vaccinated with FLUVIRIN on 02 Dec 2009. The event outcome was not reported.
Age: 1.7
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report from a healthcare professional on 13 Jan 2010: This patient with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (batch no. 10248P1), IM inadvertent administration on 12 Jan 2010. No adverse event was reported.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Needle issue, Underdose
Clinical narrative: Initial health care professional report received on 15 Jan 2010: This patient was vaccinated with FLUVIRIN on 13 Jan 2010: The patient states that the hub of the needle leaked during the time of administration. The patient did not received the full dose of FLUVIRIN vaccine. No adverse effects was reported. The seriousness criteria of the patient was not reported. Follow up report received on 14 May 2010: There was an attempt to contact reporter, but no response received so far. Therefore the case was closed with a consideration as a lost to follow up.
Sex: U
Vaccine: FLU3
Symptoms: Disorientation, Dyspnoea, Malaise, Vision blurred
Clinical narrative: Initial consumer report received on 18 Jan 2010: This patient, with an unknown medical history, was vaccinated with FLUVIRIN on 11 Sep 2009. Following the administration of the vaccine, the patient experienced blurred vision, short breath and disorientation and was rushed to an emergency on the same day. The patient was very ill for one month. The outcome of the events was not reported.
Age: 46.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Tremor
Clinical narrative: Initial report received from pharmacist on 18 Jan 2010: This patient with an unknown medical history was vaccinated with 0.5 ml FLUVIRIN (batch no. 10212591), IM on left arm on 19 Dec 2009. The patient experienced a slight tremor in his right arm on 22 Dec 2009. The patient condition was unchanged.
Sex: F
Vaccine: FLU3
Symptoms: Dermal cyst, Infection
Clinical narrative: Initial report received from Health care professional on 18 Jan 2010: This patient had a medical history of sebaceous cyst in the last 2 years. This patient received a dose of FLUVIRIN, (unknown batch no) on an unknown date on her deltoid 2-3 months ago. Ten days ago, a sebaceous cyst on her neck became infected. The physician had prescribed clindamycin as a treatment drug. The outcome of event was reported as condition unchanged. The causality of event was not reported.
Age: 21.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Needle issue, Underdose
Clinical narrative: Initial report received from a healthcare professional on 15 Jan 2010: This patient with an unknown medical history was vaccinated with FLUVIRIN (batch no. 102123A), 0.5 ml, IM on 13 Jan 2010. The reporter was reported medication error (the hub of the needle leaked during vaccination), patient did not received full dose.
Age: 46.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Injection site pain
Clinical narrative: Initial consumer report received on 19 Jan 2010: This patient with a history of hypertension was vaccinated with FLUVIRIN, Lot number 104041P1. Shortly after the vaccination the patient experienced injection site pain and became dizzy, for which he took ADVIL and kept ice at the injection site. On the morning of 16 Jan 2010, the patient experienced a scratchy sore throat, swollen glands, headache, fatigue, decreased appetite, nasal congestion and muscle aches. The patient treated his symptoms with bed rest, TYLENOL and Aspirin and ADVIL. The patient was taking AVAPRO for mild hypertension. The outcome of the events was that the patient felt much better, but symptoms, although milder still continue.
Age: 46.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Lymphadenopathy, Myalgia, Nasal congestion, Oropharyngeal pain, Throat irritation
Clinical narrative: Initial consumer report received on 19 Jan 2010: This patient with a history of hypertension was vaccinated with FLUVIRIN, Lot number 104041P1. Shortly after the vaccination the patient experienced injection site pain and became dizzy, for which he took ADVIL and kept ice at the injection site. On the morning of 16 Jan 2010, the patient experienced a scratchy sore throat, swollen glands, headache, fatigue, decreased appetite, nasal congestion and muscle aches. The patient treated his symptoms with bed rest, TYLENOL and Aspirin and ADVIL. The patient was taking AVAPRO for mild hypertension. The outcome of the events was that the patient felt much better, but symptoms, although milder still continue.
Age: 65.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Device malfunction
Clinical narrative: Initial report received from health care professional on 21 Jan 2010: This patient was vaccinated with FLUVIRIN (Lot number 104045P1) on 13 Jan 2010. During vaccination patient received retractable part of the syringe malfunctioned resulting in an undetermined amount of vaccine running down patient's arm. The seriousness criteria of the events were not reported.
Age: 46.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Dysgeusia, Immediate post-injection reaction, Nausea
Clinical narrative: Initial report received from health care professional on 21 Jan 2010: This patient was vaccinated with FLUVIRIN (Lot number 102138P1) on 21 Jan 2010. On 21 Jan 2010 immediately after vaccination the patient experienced lightheaded, queasy and metallic taste. The outcome of the events were reported as condition unchanged. The seriousness and causality of the events were not reported.
Age: 56.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Paraesthesia, Tremor
Clinical narrative: Initial report was received from the consumer on 22 Jan 2010. The patient was vaccinated with a 0.5 ml dose of FLUVIRIN in her left deltoid on 16 Jan 2010. Eighteen hours after receiving the vaccine on the same day, the patient experienced an intense tingling on the right side of her leg, extending from the knee to the toes. On 19 Jan 2010, the patient experienced that her legs were trembling uncontrollably, which caused her to see a neurologist. The patient was not recovered from the events at the time of the report. The seriousness criteria of the events was not reported.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from health care professional on 07 Jan 2010: This patient was vaccinated with FLUVIRIN (batch no. 1008134P) 0.5 ml, intramuscular, on 07 Jan 2010. The vaccine was inadvertently given to 3 years old. No adverse effect were noted after administration. The outcome of the event was not reported.
Age: 1.17
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 07 Jan 2010: This patient, with an unknown medical history was inadvertently administered FLUVIRIN (lot no: 102136P1A), intramuscularly on 14 Nov 2009. The outcome of the event was not reported. No other information was provided.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a health care professional on 07 Jan 2010: The patient was received FLUVIRIN (batch no 10127606) on 07 Jan 2010. The patient had received the FLUVIRIN at the age of 2 years on 07 Jan 2010. The outcome of the event was not reported.
Age: 1.31
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial health care professional report was received on 25 Jan 2010: This patient (15 months old) was inadvertently administered with 0.5 ml FLUVIRIN (batch number 102123P1A) on 25 Jan 2010, intramuscularly. No adverse events were reported on vaccination. The seriousness criteria of the events was not reported.
Age: 1.44
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial healthcare professional report received on 12 Jan 2010: This patient (child under the age of 4 years) received on 0.25 ml IM dose of H1N1 (batch no. 104043P1) on an unspecified date. No adverse effects were noted upon administration.
Age: 33.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report was received from a health care professional on 26 Jan 2010: This patient inadvertently received the S-OIV FLUVIRIN 0.5 ml, intramuscular (batch no. 1013262P) on 26 Jan 2010. It was reported that after five minutes of vaccination during the posy vaccination watch for an allergic reaction the patient mentioned that patient already had received a H1N1 vaccine in Dec 2009. No adverse events were reported.
Age: 1.53
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial healthcare professional report received on 12 Jan 2010: This patient (child under the age of 4 years) received a 0.25 ml IM dose of H1N1 (batch no. 104043P1) on an unspecified date. No adverse effects were noted upon administration.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Initial health care professional report received on 27 Jan 2010: This patient was inadvertently administered with 0.5 ml of FLUVIRIN (batch number 98442P1) on 25 Jan 2010, intramuscularly instead of H1N1. No adverse events were reported on vaccination.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3291. Initial case report received from a health care professional via MedCom on 26 OCT 2009. The patient, age and gender unknown, was vaccinated i.m. with S-OIV FLUVIRIN (batch no. unknown) on 23 OCT 2009. The patient, under 4 years, was inadvertently given Novartis H1N1 vaccine. No adverse event was reported. Reference no.: NA09-007031.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3292. Initial case report received from a health care professional via MedCom on 26 OCT 2009. A patient, age and gender unknown, was vaccinated i.m. with S-OIV FLUVIRIN (batch no. unknown) on 23 OCT 2009. The patient, under 4 years, was inadvertently given Novartis H1N1 vaccine. No adverse event was reported. Reference no.: NA09-007031.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3293. Initial case report received from health care professional via MedCom on 26 OCT 2009. The patient, age and gender unknown, was vaccinated i.m. with S-OIV FLUVIRIN (batch no. unknown) on 23 OCT 2009. The patient, under 4 years, was inadvertently given Novartis H1N1 vaccine. No adverse event was reported. Reference no.: NA09-007031.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a consumer on 12 Jan 2010: The patient, under the age of 4 was vaccinated with H1N1 (batch no- 104043P1) 0.5 ml once, intramuscular on 12 Jan 2010. No other information was provided at the time of this report.
Age: 1.93
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3331. Initial case report received from a physician via MedCom on 26 OCT 2009. A 23-month-old child was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3332. Initial case report received from a physician via MedCom on 26 OCT 2009. A 2-year-old patient, was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Age: 81.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abasia, Diarrhoea, Vomiting
Clinical narrative: Initial report was received from a health care professional on 08 Jan 2010: This patient had a history of chronic pain, vasovagal syncope, back surgery in 2004 and hip replacement. Patient's concurrent conditions included osteoarthritis, degenerative joint disease, irritable bowel syndrome, hypertension and chronic constipation. The patient received the S-OIV FLUVIRIN on 07 Jan 2010. On 08 Jan 2010 patient experienced vomiting and diarrhea. It was reported that patient walked to the bathroom but was unable to walk back to her bed, before this incidence patient was able to ambulate. Patient had not fever. The outcome of the events was not reported.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3333. Initial case report received from a physician via Med Com on 26 OCT 2009. A 2-year-old patient, was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Age: 0.51
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from health care professional on 08 Jan 2010: This patient was vaccinated with FLUVIRIN (batch no. 102125P) 0.25 ml, intramuscular (injected into thigh), on unknown date. The vaccine was inadvertently given to 6 months old. No adverse effect was noted after administration. The outcome of event was not reported.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case  previously recorded as MA2009-3334. Initial case report received from a physician via MedCom on 26 OCT 2009. A 2-year-old patient, was vaccinated with 0.5 ml FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from health care professional on 11 Jan 2010: This three year old boy received a 0.5 ml of Novartis H1N1 vaccine (batch no. 1013266P) at deltoid on 09 Jan 2010. No other information was reported. After internal review on 12 Jan 2010 of the data received on 11 Jan 2010, it was identified that the suspect drug has been wrongly coded. The suspect drug has been recoded to S-OIV FLUVIRIN.
Age: 0.57
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3335. Initial case report received from a physician via Med Com, on 26 OCT 2009. A 7-month-old child was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no. 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Age: 1.59
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a nurse on 12 Jan 2010: This patient was vaccinated with H1N1 2009 vaccine (influenza virus vaccine monovalent) (batch no: 102149P1) 0.25 ml intramuscular for immunisation, on 11 Jan 2010. The patient under 4 years of age was vaccinated with 0.25 ml dose of Novartis H1N1. No other information was provided at the time of this report.
Age: 0.66
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3336. Initial case report received from a physician via MedCom on 26 OCT 2009. A 8-month-old child was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Drug exposure during pregnancy, Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3339. Initial case report received from a health care professional via MedCom on 28 OCT 2009. A female patient, age unknown, was vaccinated i.m. with 0.5 ml S-OIV FLUVIRIN (batch no. 100739) in the arm on 27 OCT 2009 and 28 OCT 2009. The patient was pregnant at time of vaccination. On 28 OCT 2009 she received a second Novartis H1N1 vaccine dose instead of FLUVIRIN. No adverse event was reported. Reference no.: NA09-007176.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3372. Initial case report received from a nurse via Med Com on 29 OCT 2009. A 2-year-old female patient was vaccinated with S-OIV FLUVIRIN (batch no 10073802) i.m. into the right deltoid on 28 OCT 2009. No adverse event was reported. Reference no. NA09-007194.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3425. Initial case report received from a consumer via MedCom, on 28 OCT 2009. A 2-year-old male child was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no. unknown) i.m. on 28 OCT 2009. S-OIV FLUVIRIN 0.5 ml was given to a 2-years-old child. Upon reading the package insert, the mother noted that the product was not indicated for children below the age of 4 years. No adverse event was reported. Reference no.: NA09-007196.
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Drug exposure during pregnancy, Incorrect storage of drug, No adverse event
Clinical narrative: Case previously recorded as MA2009-3454. Initial case report received via MedCom from a health care professional on 30 OCT 2009: multiple pregnant female patients (no further information available) were vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. unknown) i.m. on 29 OCT 2009. The vaccine may had been exposed to temperatures between 79 and 80 F. No adverse event was reported. MedCom ref. no.: NA09-007291. Follow up report received on 26 Apr 2010: There were two attempts to contact reporter, but no response received so far. Therefore the case was closed with a consideration as a lost to follow up.
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Incorrect route of drug administration, No adverse event
Clinical narrative: Case previously recorded as MA2009-3457. Initial case report received from a health care professional on 02 NOV 2009. The patient, age and gender was unknown, was vaccinated intragluteal with 0.5 ml FLUVIRIN (batch no. 100813P) on 28 OCT 2009. The patient received the vaccine intragluteal instead of intramuscular. No adverse event was reported The reporter was unsure on the date of vaccination, unable to provide any additional information and not willing to provide contact information for the party reporting the incident to her.
Age: 1.3
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event, Off label use
Clinical narrative: Case previously recorded as MA2009-3458. Initial case report received from a registered nurse via MedCom on 30 OCT 2009. A 15-month-old female patient was vaccinated i.m. with 0.25 ml S-OIV FLUVIRIN (batch no. 1007393P). The patient, under 4 years, was inadvertently given Novartis H1N1 vaccine. No adverse event was reported. Reference no.: NA09-007320.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial report received from a nurse on 12 Jan 2010: This patient who was under 4 years of age received Novartis H1N1 (batch number 102149P1) 0.25 ml intramuscularly on 11 Jan 2010. Outcome was not provided at the time of this report.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from a nurse on 12 Jan 2010. This patient below 4 years of age, received a 0.25 ml dose of Novartis H1N1 on 11 Jan 2010. No adverse event occurred. Following internal review on 13 Jan 2010 of the data received on 12 Jan 2010, the following correction was made: The product was recoded to S-OIV FLUVIRIN.
Age: 3.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Initial consumer report received on 12 Jan 2010: This patient who was 3.5 year old received H1N1 (batch number 1013285P) 0.5 mL intramuscular dose on 07 Jan 2010. Outcome was not provided at the time of this report.
Age: 2.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Combined initial consumer report received on 12 Jan 2010: This patient who was 2 year old received Novartis H1N1 (Batch number 102149P1) intramuscular dose on 07 Jan 2010. The dose was the second in the H1N1 vaccination series. Timing of the vaccination was unavailable. Outcome was not provided. No further information including the first vaccination time, was not available.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event, Off label use
Clinical narrative: Initial report received from a health care professional on 12 Jan 2010: This patient was received FLUVIRIN (batch no. 104043P1, exp date: 30 Apr 2010) on 12 Jan 2010. He was received the FLUVIRIN under the age of 4. The patient did not have a adverse event. The outcome of the event off label use was not reported.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from a health care professional on 12 Jan 2010: This patient was received FLUVIRIN (batch no. 104043P1, exp date 30 Apr 2010) on 12 Jan 2010. The patient under the age of 4 received a 0.25ml dose of FLUVIRIN. No adverse event was reported. The outcome of the event off label use was not reported.
Age: 3.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: Initial report received from a nurse on 13 Jan 2010: This patient (under four years of age) was vaccinated with 0.25 ml of FLUVIRIN (batch number: 102133P) intramuscularly on 13 Jan 2010. No adverse event was reported. The reporter also reported two other companion cases (See case PHHY2010US01708 and PHHY2010US01744).